Instruments for oral disease-intervention strategies: Recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis

Vaccine

Volumn 17, Issue 17, 1999, Pages 2117-2128

  Maassen, C B M ^a,b   Laman, J D ^a,b   Heijne Den Bak Glashouwer, M J ^a   Tielen, F J ^a   Van Holten Neelen, J C P A ^a   Hoogteijling, L ^a   Antonissen, C ^a   Leer, R J ^a   Pouwels, P H ^a   Boersma, W J A ^c   Shaw, D M ^a  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Experimental autoimmune allergic encephalomyelitis (EAE); Heterologous gene expression; Mucosal vaccines

Indexed keywords

LACTOBACILLUS VACCINE; MYELIN PROTEIN; RECOMBINANT VACCINE;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOGENICITY; LACTOBACILLUS CASEI; MULTIPLE SCLEROSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TETANUS; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL VACCINES; CATTLE; FLOW CYTOMETRY; GENETIC VECTORS; GUINEA PIGS; HUMANS; IMMUNE TOLERANCE; IMMUNOHISTOCHEMISTRY; LACTOBACILLUS CASEI; MICE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RABBITS; RECOMBINANT FUSION PROTEINS; TETANUS; TETANUS TOXIN;

EID: 0033597103     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00010-9     Document Type: Article

References (31)

1. Czerkinsky C., Holmgren J. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. The Immunologist. 3:1995;97-103.
2. Brandtzaeg P. History of oral tolerance and mucosal immunity. Ann. NY Acad. Sci. 778:1996;1-27.
3. Gebert A., Rothkotter H.J., Pabst R. M cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:1996;91-159.
4. Strobel S., Mowat A.M., Drummond H.E., Pickering M.G., Ferguson A. Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen. Immunology. 49:1983;451-456.
5. Mowat A.M. The role of antigen recognition and suppressor cells in mice with oral tolerance to ovalbumin. Immunology. 56:1985;253-260.
6. Maassen C.B.M., Gerritse K., Leer R.J., Heemskerk D., Boersma W.J.A., Claassen E. Lactobacillus as a vector for oral delivery of antigens: The role of intrinsic adjuvanticity in modulation of the immune response. Husband A., et al. Mucosal solutions, Advances in Mucosal Immunology, part 2. 1998;235-247 The University of Sydney, Sydney, Australia.
7. Bitar D.M., Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112:1988;364-370.
8. Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140:1988;440-445.
9. Challacombe S.J., Tomasi T.B.J. Systemic tolerance and secretory immunity after oral immunization. J. Exp. Med. 152:1980;1459-1472.
10. Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA. 93:1996;11341-11348.
11. Perdigon G., Alvarez S., Pesce de Ruiz Holgado A.A. Immunoadjuvant activity of oral Lactobacillus casei: influence of dose on the secretory immune response and protective capacity in intestinal infections. J. Dairy Res. 58:1991;485-496.
12. Boersma W.J.A., Zegers N.D., Van den Bogaerd A., Leer R.J., Bergmans A., Pouwels P.H., Posno M., Claassen E. Development of safe oral vaccines based on Lactobacillus as a vector with adjuvant activity. Proc. ICHEM 2nd Int. Congr. Biotech., UK, Brighton. 1994;43-46.
13. Link-Amster H., Rochat F., Saudan K.Y., Mignot O., Aeschlimann J.M. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol. Med. Microbiol. 10:1994;55-63.
14. Pouwels P.H., Leer R.J., Boersma W.J.A. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44:1996;183-192.
15. Gerritse K., Posno M., Schellekens M.M., Boersma W.J.A., Claassen E. Oral administration of TNP-Lactobacillus conjugates in mice: a model for evaluation of mucosal and systemic immune responses and memory formation elicited by transformed lactobacilli. Res. Microbiol. 141:1990;955-962.
16. Fairweather N.F., Chatfield S.N., Makoff A.J., Strugnell R.A., Bester J., Maskell D.J., Dougan G. Oral vaccination of mice against tetanus by use of a live attenuated Salmonella carrier. Infect. Immun. 58:1990;1323-1326.
17. Robinson K., Chamberlain L.M., Schofield K.M., Wells J.M., Le Page R.W. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:1997;653-657.
18. Hanahan D. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:1983;557-580.
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor University Press, Cold Spring Harbor, NY.
20. Posno M., Leer R.J., van Luijk N., van Giezen M.J.F., Heuvelmans P.T.H.M., Lokman B.C., Pouwels P.H. Complementation of the inability of Lactobacillus strains utilize D-xylose with D-xylose catabolism-encoding genes of Lactobacillus pentosus. Appl. Environ. Microbiol. 57:1991;1822-1828.
21. Efthymiou C., Hansen P.A. Antigenic analysis of Lactobacillus acidophilus. J. Infect. Dis. 110:1962;258-267.
22. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
23. Hackett C.J., Hurwitz J.L., Dietzschold B., Gerhard W. A synthetic decapeptide of influenza virus hemagglutinin elicits helper T cells with the same fine recognition specificities as occur in response to whole virus. J. Immunol. 135:1985;1391-1394.
24. Pouwels P.H., Leer R.J. Genetics of lactobacilli: plasmids and gene expression. Antonie van Leeuwenhoek. 64:1993;85-107.
25. Pinder A.C., Purdy P.W., Poulter S.A., Clark D.C. Validation of flow cytometry for rapid enumeration of bacterial concentrations in pure cultures. J. Appl. Bacteriol. 69:1990;92-100.
26. Samuelson P., Hansson M., Ahlborg N., Andreoni C., Gotz F., Bachi T., Nguyen T.N., Binz H., Uhlen M., Stahl S. Cell surface display of recombinant proteins on Staphylococcus carnosus. J. Bacteriol. 177:1995;1470-1476.
27. Hols P., Slos P., Dutot P., Reymund J., Chabot P., Delplace B., Delcour J., Mercenier A. Efficient secretion of the model antigen M6-gp41E in Lactobacillus plantarum NCIMB 8826. Microbiology. 143:1997;2733-2741.
28. Saunders C.W., Schmidt B.J., Mallonee R.L., Guyer M.S. Secretion of human serum albumin from Bacillus subtilis. J. Bacteriol. 169:1987;2917-2925.
29. Simonen M., Palva I. Protein secretion in Bacillus species. Microbiol. Rev. 57:1993;109-137.
30. Wells J.M., Wilson P.W., Norton P.M., Le P.R. A model system for the investigation of heterologous protein secretion pathways in Lactococcus lactis. Appl. Environ. Microbiol. 59:1993;3954-3959.
31. Gerritse K., Posno M., Fasbender M.J., Schellekens M.M., Boersma W.J.A., Claassen E. Mucosal immune responses and systemic immunological memory after oral administration of trinitrophenyl Lactobacillus conjugates in mice. Lymphatic Tissues and in vivo Immune Responses. 84:1991;497-504.